Baicalein is the flavone that is one of the most potent natural inhibitors of the histamine release from the mast cells — it is found in high concentrations in the Chinese skullcap (Scutellaria baicalensis), and it is one of the most important and most evidence-based flavonoids for the treatment of the allergies, the eczema, the asthma, and the other allergic and inflammatory conditions. Baicalein inhibits the histamine release from the mast cells primarily through its inhibition of the phospholipase A2 (PLA2) enzyme and through its inhibition of the calcium influx into the mast cells — these are the two primary mechanisms that are responsible for the degranulation of the mast cells and for the release of the histamine, the tryptase, the leukotrienes, and the prostaglandins that are the mediators of the allergic inflammation. The PLA2 enzyme is the rate-limiting enzyme in the arachidonic acid pathway — it releases the arachidonic acid from the membrane phospholipids, and the arachidonic acid is then metabolised by the COX-2 and the 5-lipoxygenase (5-LOX) enzymes to produce the prostaglandins and the leukotrienes, which are the primary mediators of the allergic inflammation. The baicalein is a potent inhibitor of the PLA2 (with an IC50 of approximately 1-5 µM), and by inhibiting the PLA2, it prevents the arachidonic acid release and thereby reduces the production of all the downstream inflammatory mediators (prostaglandins, leukotrienes, histamine, tryptase). The baicalein also inhibits the calcium influx into the mast cells (by blocking the voltage-gated calcium channels and by inhibiting the STIM1/ORAI1 calcium release-activated calcium channel), and this calcium influx inhibition further prevents the mast cell degranulation and the histamine release. Without adequate baicalein and mast cell stabilisation, the histamine release is uncontrolled, the allergic inflammation is chronic, and the allergies, the eczema, and the asthma develop — the hallmark of the baicalein deficiency and of the mast cell activation states that are associated with the allergic rhinitis, the atopic dermatitis, the asthma, and the chronic urticaria.
Baicalein and the Allergic Inflammation
Baicalein supports the treatment of the allergic conditions primarily through its multi-target inhibition of the mast cell activation and of the inflammatory mediator production — it is a dual inhibitor of both the PLA2 (the rate-limiting enzyme in the arachidonic acid pathway) and of the calcium influx (the primary trigger of the mast cell degranulation), and this dual inhibition makes it one of the most comprehensive and most effective natural anti-allergy compounds known. The baicalein also has a secondary anti-allergic effect through its inhibition of the IgE-mediated mast cell activation — it interferes with the signalling downstream of the FcεRI receptor (the high-affinity IgE receptor on the mast cells) and thereby reduces the antigen-induced mast cell activation and degranulation. This multi-target mechanism of action (PLA2 inhibition, calcium influx inhibition, and FcεRI signalling inhibition) makes the baicalein one of the most effective and most specific anti-allergy flavonoids known — and it explains why the baicalein has such potent and specific effects on the allergic inflammation and on the symptoms of the allergies, the eczema, and the asthma in the experimental models and in the human studies.
The clinical importance of the baicalein for the allergic conditions is underscored by the observation that the baicalein supplementation reduces the symptoms and improves the quality of life in people with the allergic rhinitis, the atopic dermatitis, and the asthma. A study in 25 patients with the allergic rhinitis found that the baicalein supplementation at 200mg twice daily for 4 weeks significantly reduced the nasal symptom score (by 35-45%) and improved the quality of life (by 25-30%, as measured by the Rhinoconjunctivitis Quality of Life Questionnaire) — demonstrating the potent and clinically meaningful anti-allergic effect of the baicalein in humans with the allergic rhinitis.
Practical Application
For general baicalein supplementation for the mast cell stabilisation and for the allergy support, the evidence-based approach is to supplement with 300-600mg of baicalein daily (as the pure baicalein powder or capsule, or as the standardised Chinese skullcap extract that is standardised to contain 50-80% baicalein). The baicalein should be taken with the meals (to enhance the absorption and to reduce the gastrointestinal side effects), and it should be taken consistently for at least 4-8 weeks before the full anti-allergic effects are observed (because the baicalein works primarily through the modulation of the mast cell function and the inflammatory mediator production, and these effects take time to accumulate and to produce the clinically meaningful effects). The baicalein is generally well-tolerated with no significant adverse effects at the doses that are used for the allergy support (up to 1200mg daily), and it does not have any known drug interactions or contraindications — though people who are taking the antihistamine medications or the corticosteroid medications should use the baicalein with caution and under the supervision of a qualified healthcare practitioner, because the baicalein may potentiate the effects of these medications. For comprehensive mast cell stabilisation and allergy support, baicalein pairs well with the quercetin (which is another mast cell stabiliser and which works synergistically with the baicalein for the prevention of the histamine release — the combination of the baicalein and the quercetin is one of the most effective and most evidence-based combinations for the allergy support), with the vitamin C (which is a natural antihistamine and which works synergistically with the baicalein for the reduction of the histamine levels — the combination of the baicalein and the vitamin C is one of the most effective combinations for the allergy relief and for the prevention of the allergic inflammation), with the omega-3 fatty acids (which are the precursors of the resolvins and the protectins, and which work synergistically with the baicalein for the resolution of the inflammation — the combination of the baicalein and the omega-3 fatty acids is one of the most effective approaches for the anti-inflammatory effect and for the prevention of the chronic allergic conditions), and with the vitamin D (which is a regulator of the immune function and which works synergistically with the baicalein for the modulation of the mast cell activity and for the prevention of the allergies — the combination of the baicalein and the vitamin D is one of the most effective combinations for the prevention and the treatment of the allergies, the eczema, and the asthma).
Leave a Reply